Robotic Technology Transforming Therapeutic GI

Easy, Accurate and Safe
Endoscopic Removal of Complex Lesions

Robotic Polypectomy Reimagined

The Need

En-bloc removal of gastrointestinal polyps is a cornerstone of colorectal and gastric cancer treatment and a crucial preventative measure, safeguarding against potential malignancies while improving overall GI health.

Traditional approaches require an additional visit after the initial screening examination, leading to increased healthcare expenses, added complexity, and challenge patient compliance issues.

Robotic Polypectomy Reimagined

Current alternatives have substantial faults:

Open or laparoscopic procedures

Major operations that are highly invasive, complex, and expensive, with significant patient risks.

EMR


(Endoscopic Mucosal Resection)
Is often incomplete for flat or large lesions, preventing margin assessment and potentially increasing the risk of malignant cell spread.

ESD

(Endoscopic Submucosal Dissection)
Technically demanding, requiring extensive training, and posing elevated complications risk, such as bleeding and perforations, requiring careful intraoperative management.

Open or laparoscopic procedures

Major operations that are highly invasive, complex, and expensive, with significant patient risks.

EMR


(Endoscopic Mucosal Resection)
Is often incomplete for flat or large lesions, preventing margin assessment and potentially increasing the risk of malignant cell spread.

ESD

(Endoscopic Submucosal Dissection)
Technically demanding, requiring extensive training, and posing elevated complications risk, such as bleeding and perforations, requiring careful intraoperative management.

Our Solution

MicroSteer delivers a breakthrough solution for the removal of complex lesions within the gastrointestinal tract, offering significant advantages for both patients and healthcare providers. Designed for seamless integration, the device attaches to most commercially available colonoscopes and gastroscopes and operates with standard off-the-shelf tools. Its precise, automated control enables accurate dissection and facilitates complete en-bloc tissue removal, ensuring optimal histopathological analysis and improved clinical outcomes.

Easy
to Master

Streamline the procedure, making it intuitive and straightforward, far easier to learn and master than ESD.

Improved Efficacy

Robotic precision and automated control enables precise dissection, ensuring complete en-bloc tissue removal for reliable histopathological analysis.

Enhanced Safety

Precise control of the cutting tool minimizes unintentional movements, significantly reduces the risk of perforation, improving patient safety.

Cost Savings

Shorten lesion removal time and procedure duration. The option to combine the procedure with the screening colonoscopy may further save time, reduce healthcare costs and optimize resources.

We’re setting a new standard in endoscopic care –
Simplifying access to complex medical techniques , efficient and safe for both patients and providers.

About

Microsteer Logo

MicroSteer is addressing a critical need in gastrointestinal care of intraoperative removal of complex lesions.

MicroSteer is developing a novel, semi-automated technology designed for complex polypectomies traditionally associated with EMR (Endoscopic Mucosal Resection) and ESD (Endoscopic Submucosal Dissection). MicroSteer’s introduces the first steered polypectomy device, empowering endoscopists to perform safer and faster procedures, that were previously limited to highly experienced interventional gastroenterologists. The system facilitates variable range of adjustable cutting devices guided along a pre-defined, programmed exact track – delivering unmatched precision, efficiency, and confidence in en-bloc tissue removal.

Management Team

Ofer Pillar

Cofounder and Board Member
Founder and CEO of CByond and six additional life-science startups, VP BD Gyrus-ACMI (sold to Olympus for $2.1b), Chairman of NGT3 Investment Committee.


Eyal Ben-Esti

Chief Executive Officer
Business and technological leader, with strong engineering background, savvy in medical device development processes, transforming concept ideation to launch and sales.

Adi Strauss

Cofounder and CTO
Serial entrepreneur, founder and board member of MDD-Israel and Fertigo Medical, medical device innovator with over two decades of experience from Mazor Robotics, Stryker GI, Elbit Systems and other large-scale companies.

Scientific Advisory Board

Dr. Amyn Haji

Director of London
Endosurgery
  • Consultant Colorectal & Laparoscopic
  • Surgeon at King’s College Hospital, London
  • Lead for Complex Polyps and Early Cancer

Prof. Shivangi
Kothari

Endoscopy Director, Rochester University, NY
  • Associate Professor of Medicine and Associate Director of Endoscopy at the University of Rochester Medical Center
  • 2024 ACG Governor's Service Award for contributions to gastroenterology.

Prof. Ken Ohata

Director of Endoscopy, NTT
  • Chief Gastroenterology and Director of the Endoscopy Center at NTT, Medical Center Tokyo
  • Over 15 years of ESD experience and ~3,500 procedures performed

Dr. Ari Benson

Head of Endoscopy Unit,
SZMC
  • Director of Endoscopy Unit, Shaare Zedek Medical Center
  • Fellowship in Advanced Endoscopy, Hadassah Medical Center
  • ESD training in Kobe, Japan

Dr. Sergei Vosko

Head of Endoscopy Unit, Hadassah
  • Director of Endoscopy Unit, Hadassah Medical Center
  • Founder of the Advanced Endoscopic Resection Unit at Shamir Medical Center
  • Training in Advanced Endoscopy in Westamide Hospital, Sydney

Intellectual Property

MicroSteer is dedicated to protecting its intellectual property, actively seeking patent protection across major global markets. The products and patent numbers listed below represent a substantial portion of our portfolio though they do not include all pending or granted patents. We continue to advance additional patents that are currently under review. For further details on granted patents and published U.S. patent applications, please visit the United States Patent and Trademark Office website. Published international patent applications may be viewed at the World Intellectual Property Organization website.

EP4061256A1, US12426907, JP7741557

These patents describe a medical device that assists endoscopist access and treat raised tissues, such as polyps or tumors. It works by placing a special rail near the targeted tissue inside the body. A small robotic vehicle, carrying surgical tools like a cutter, moves along this rail, allowing doctors to reach and operate different sides of the tissue without needing to reposition their instruments manually. This approach aims to make procedures less invasive, safer and more accurate, improving outcomes for patients.

News

Contact Us

For More Information

MicroSteer Logo

Supported by